Unknown NA INTERVENTIONAL 4-arm NCT03749577

Nutritional Strategies to Increase Nitric Oxide Signaling in Raynaud's Phenomenon (NivOSe)

Sponsor: University Hospital, Grenoble

Interventions Beetroot juice Denitrated beetroot juice L-citrulline L-citrulline placebo

Updated 8 times since 2018 Last updated: May 12, 2021 Started: Oct 1, 2020 Primary completion: Apr 30, 2022 Completion: Jun 30, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Raynaud Phenomenon and is currently ongoing. University Hospital, Grenoble leads this study, which shows 8 recorded versions since 2020 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jun 2023 — Jul 2024 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status
Jun 2021 — Jun 2023 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting
Jan 2021 — Jun 2021 [monthly]

Not Yet Recruiting NA

▶ Show 3 earlier versions

Nov 2019 — Jan 2021 [monthly]

Not Yet Recruiting NA
Feb 2019 — Nov 2019 [monthly]

Not Yet Recruiting NA
Dec 2018 — Feb 2019 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University Hospital, Grenoble
University Hospital, Rouen

Data source: University Hospital, Grenoble

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Grenoble, France